NCL Industries Q3 Update: Cement production falls 12%, doors segment grows 39%

Cement dispatches also dropped 11% YoY to 6.62 lakh tonnes from 7.41 lakh tonnes. Shares of NCL Industries Ltd ended at ₹204, down by ₹0.15, or 0.073%, on the BSE.

Cement dispatches also dropped 11% YoY to 6.62 lakh tonnes from 7.41 lakh tonnes. Shares of NCL Industries Ltd ended at ₹204, down by ₹0.15, or 0.073%, on the BSE.

AMPIN C&I Power will hold a 74% stake in the joint venture while the rest will be with Poly Medicure. Shares of Poly Medicure Ltd ended at ₹2,684, down by ₹8, or 0.30%, on the BSE.

From Ashok Leyland and Coforge to HCL Technologies and Rainbow Children Medicare, these stocks offer potential for both short- and long-term growth. Mirae Asset Capital Markets highlights its top eight stock picks for January 2025, emphasising strong growth prospects across…

As of Friday’s close, Anand Rathi Wealth has a market capitalisation of close to ₹18,000 crore. Promoters of the company hold 47.99% stake in the company at the end of the September quarter, while the December shareholding is yet to…

Markets regulator SEBI has renewed its recognition of AMC Repo Clearing Ltd as a clearing corporation for one year till January 16, 2026 for clearing and settling transactions in repo and reverse repo in debt securities.

EBITDA grew 13.7% to ₹ 317.4 crore in the third quarter of this fiscal over ₹279.1 crore in Q3 FY24. Shares of PCBL Chemical Ltd ended at ₹391.20, down by ₹6.70, or 1.68% on the BSE.

The benchmark Nifty50 gained nearly 9% in 2024, extending gains for the ninth consecutive year. While investors earned a whopping ₹78 lakh crore in 2024, there are some stocks that witnessed erosion in investor wealth, while many failed to keep…

The rupee declined 14 paise and touched the crucial 86.00mark (provisional) for the first time against the US dollar on Friday as it failed to resist pressure from a stronger American currency and huge outflow of foreign funds.

This is the largest-ever primary fundraise in the Indian diagnostics segment and the first private equity round for Neuberg Diagnostics.

For PFC, consensus now projects a potential upside of 51% from current levels, while for REC, the potential upside stands at 47%.